Improving outcomes of childhood neuroblastoma

Nivolumab produces long-lasting responses in patients with stage IV melanoma

Delayed relapse of advanced ovarian cancer when treating with pazopanib

Cetuximab superior to bevacizumab for advanced colorectal cancer

New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma

Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer

Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone

State of CNS germ cell tumour research in North America

Overview of germ cell tumour research in North America

New targets for squamos cell carcinoma

European Thoracic Oncology Platform